Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

ADSC-Exos with miR-122-5p can help treat hair loss by promoting hair growth.

Immune activities and specific genes are important in male pattern baldness.

Hidradenitis suppurativa is linked to various diseases like obesity, depression, arthritis, and Crohn's disease, but often occurs alone.

Epidermal nevi are skin cell clusters linked to various syndromes.

Pomegranate has health benefits and new methods are improving its use in supplements.

Diet can influence inflammatory skin diseases.

Some steroid-induced health issues in rodents improved after stopping treatment, but hair loss and eye problems did not.

Mice without certain skin enzymes have faster hair growth and bigger eye glands.

Antioxidant nanoparticles show promise for treating inflammatory diseases but need more research for safe and effective use.

The comprehensive treatment with biomimetic peptide lotion was effective for hair loss.

Oxidative stress and immune dysfunction are linked to both Hashimoto's thyroiditis and polycystic ovary syndrome, with diet and specific treatments important for managing these conditions.

Lavender, lemongrass, rosemary, and chamomile essential oils may help protect cells important for hair growth from damage and could promote hair growth.

The chapter explains common scalp conditions, including infections, infestations, and tumors.

The new scalp therapy shows promise for hair growth but needs more research.

Methionine supplementation in low-protein diets improves growth, fur quality, and gut health in blue foxes.

Mitochondrial dysfunction links metabolic syndrome and inflammatory skin diseases, suggesting targeted therapies and lifestyle changes.

Higher levels of β-carotene and vitamin E may help prevent certain types of hair loss.

Wound healing is not fully understood, requiring more research and collaboration to improve treatments.

New treatments like nanotechnology show promise in improving skin cancer therapy.

Polycystic Ovary Syndrome should be seen mainly as a condition of excess male hormones, with a focus on this in its definition.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

People with hair loss have more androgen receptors and enzymes in certain follicles, with men and women showing different patterns.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Most women referred for excess male hormone symptoms had polycystic ovary syndrome (PCOS), with other conditions being less common.

Mutations in the androgen receptor gene cause androgen insensitivity, leading to female traits in genetically male individuals.

Male pattern baldness is linked to specific genetic variations in the androgen receptor gene.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Exposure to too much androgen before birth might cause polycystic ovary syndrome later in life.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.